SEARCH RESULTS for assignee:"BRISTOL-MYERS SQUIBB COMPANY"

Recent Patent Assignments Patent Assignments - (Total found: 69)

Last Update Patent(s) Assignor(s) Orig. Assignee(s) Assignee(s) Reel/Frame
15-May-2018

(X0) 1: VOICE INTERFACES IN PROCESS CONTROL SYSTEMS

(A1) 2: VOICE INTERFACES IN PROCESS CONTROL SYSTEMS

(B2) 9: VOICE INTERFACES IN PROCESS CONTROL SYSTEMS

PANNEERSELVAM, RANJITHKUMAR

SZUREK, SCOTT

STAPLER, TYLER SCOTT

BRISTOL, INC., D/B/A REMOTE AUTOMATION SOLUTIONS

38017/822

15-May-2018

(X0) 1: OXOLUPENE DERIVATIVES

(A1) 2: OXOLUPENE DERIVATIVES

(B2) 9: OXOLUPENE DERIVATIVES

REGUEIRO-REN, ALICIA

LIU, ZHENG

SWIDORSKI, JACOB

MEANWELL, NICHOLAS A.

BRISTOL-MYERS SQUIBB COMPANY

42235/842

11-May-2018

(X0) 1: CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING

(A1) 2: CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING

COGSWELL, JOHN P.

GOLDBERG, STACIE M.

GUPTA, ASHOK K.

JURE-KUNKEL, MARIA

WANG, XI-TAO

WIGGINTON, JON M.

BRISTOL-MYERS SQUIBB COMPANY

45762/37

10-May-2018

(X0) 1: TRICYCLIC SULFONES AS ROR GAMMA MODULATORS

(A1) 2: TRICYCLIC SULFONES AS ROR GAMMA MODULATORS

MARCOUX, DAVID

BERTRAND, MYRA BEAUDOIN

DHAR, T.G. MURALI

YANG, MICHAEL G.

XIAO, ZILI

XIAO, HAI-YUN

ZHU, YEHENG

WEIGELT, CAROLYN A.

BATT, DOUGLAS G.

BRISTOL-MYERS SQUIBB COMPANY

44262/54

10-May-2018

(X0) 1: TGF-Beta Inhibitors

(A1) 2: TGF-Beta Inhibitors

BORZILLERI, ROBERT M.

VELAPARTHI, UPENDER

LIU, PEIYING

DARNE, CHETAN

BRISTOL-MYERS SQUIBB COMPANY

44534/738

10-May-2018

(X0) 1: TGF-Beta Inhibitors

(A1) 2: TGF-Beta Inhibitors

BRISTOL-MYERS SQUIBB COMPANY

44534/805

10-May-2018

(X0) 1: ANTIBODIES AGAINST CD73 AND USES THEREOF

(A1) 2: ANTIBODIES AGAINST CD73 AND USES THEREOF

LONBERG, NILS

KORMAN, ALAN J.

BARNHART, BRYAN C.

YAMNIUK, AARON P.

SRINIVASAN, MOHAN

HENNING, KARLA A.

LEI, MING

SEGA, EMANUELA

GOODENOUGH, ANGELA

JURE-KUNKEL, MARIA N.

CHEN, GUODONG

SACK, JOHN S.

HUANG, RICHARD

CORBETT, MARTIN J.

MYERS, JOSEPH E., JR.

SCHWEIZER, LIANG

HATCHER, SANDRA V.

BRISTOL-MYERS SQUIBB COMPANY

45074/690

10-May-2018

(X0) 1: ANTIBODIES AGAINST CD73 AND USES THEREOF

(A1) 2: ANTIBODIES AGAINST CD73 AND USES THEREOF

HUANG, HAICHUN

ZHANG, PINGPING

BRISTOL-MYERS SQUIBB COMPANY

45074/736

03-May-2018

(X0) 1: COMBINATION OF ANTI-KIR AND ANTI-CTLA-4 ANTIBODIES TO TREAT CANCER

(A1) 2: COMBINATION OF ANTI-KIR AND ANTI-CTLA-4 ANTIBODIES TO TREAT CANCER

GRAZIANO, ROBERT F.

GUPTA, ASHOK K.

KIM, SU YOUNG

WIGGINTON, JON

BRISTOL-MEYERS SQUIBB COMPANY

43922/939

02-May-2018

(X0) 1: Water Heater Demand Side Management System

(A1) 2: Water Heater Demand Side Management System

BRISTOL TENNESSEE ESSENTIAL SERVICES

45682/499

26-Apr-2018

(X0) 1: CONTROL UNIT ASSEMBLY

(A1) 2: CONTROL UNIT ASSEMBLY

TABRON, IAN STEWART

BONNEFIN, WAYNE LEE

LINNANE, PATRICK GERRARD

LOOF, STEFAN

BERGENS, THOMAS

BAKER, TROY A.

WILSON, GRAHAM PETER

TUCKER, CARL ESTCOURT

BRISTOL-MYERS SQUIBB COMPANY

44838/25

26-Apr-2018

(X0) 1: ANTIPROLIFERATIVE COMPOUNDS AND CONJUGATES MADE THEREFROM

(A1) 2: ANTIPROLIFERATIVE COMPOUNDS AND CONJUGATES MADE THEREFROM

MCDONALD, IVAR M.

SIVAPRAKASAM, PRASANNA

IWUAGWU, CHRISTIANA I.

PEESE, KEVIN M.

CHENG, HENG

CHOWDARI, NAIDU S.

GANGWAR, SANJEEV

BRISTOL-MYERS SQUIBB COMPANY

45231/319

20-Apr-2018

(X0) 1: SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS

(A1) 2: SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS

MITCHELL, TRACY S.

GOSSELIN, MICHAEL L.

LIPOVSEK, DASA

PARKER, REX

CAMPHAUSEN, RAY

DAVIS, JONATHAN

FABRIZIO, DAVID

BRISTOL-MYERS SQUIBB COMPANY

45589/30

18-Apr-2018

PEACOCK MYERS, P.C.

45562/183

17-Apr-2018

(X0) 1: Laminate

(A1) 2: Laminate

(B2) 9: Laminate

CASTILLO, WILFRED L.

MERCADO, GRACE N.

BRISTOL-MYERS SQUIBB COMPANY

18469/645

17-Apr-2018

(X0) 1: Immunomodulators

(A1) 2: Immunomodulators

(B2) 9: Immunomodulators

SUN, LI-QIANG

ZHAO, QIAN

GILLIS, ERIC P.

MILLER, MICHAEL MATTHEW

ALLEN, MARTIN PATRICK

MULL, ERIC

SCOLA, PAUL MICHAEL

BRISTOL-MYERS SQUIBB COMPANY

37790/804

17-Apr-2018

(X0) 1: RECTAL DRAIN APPLIANCE

(A1) 2: RECTAL DRAIN APPLIANCE

(B2) 9: RECTAL DRAIN APPLIANCE

BRISTOL-MEYERS SQUIBB COMPANY

38413/158

17-Apr-2018

(X0) 1: BENZOTHIAZOLE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

(A1) 2: BENZOTHIAZOLE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

(B2) 9: BENZOTHIAZOLE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

NAIDU, B. NARASIMHULU

PATEL, MANOJ

BRISTOL-MYERS SQUIBB COMPANY

41166/802

17-Apr-2018

(X0) 1: SUCCINOYLAMINOBENZODIAZEPINES AS INHIBITORS OF ABETA PROTEIN PRODUCTION

(A1) 2: SUCCINOYLAMINOBENZODIAZEPINES AS INHIBITORS OF ABETA PROTEIN PRODUCTION

(B2) 7: SUCCINOYLAMINOBENZODIAZEPINES AS INHIBITORS OF ABETA PROTEIN PRODUCTION

BRISTOL-MYERS SQUIBB PHARMA COMPANY

45544/777

17-Apr-2018

(X0) 1: SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF ABETA PROTEIN PRODUCTION

(A1) 2: SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF ABETA PROTEIN PRODUCTION

(B2) 7: SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF ABETA PROTEIN PRODUCTION

BRISTOL-MYERS SQUIBB PHARMA COMPANY

45544/796